April 2011
Volume 52, Issue 14
Free
ARVO Annual Meeting Abstract  |   April 2011
Lens Crystallin Modification and Aggregation by Ascorbic Acid Oxidation: In Vitro and In Vivo Study
Author Affiliations & Notes
  • Xingjun Fan
    Pathology,
    Case Western Reserve Univ, Cleveland, Ohio
  • Shuyu Hao
    Pathology,
    Case Western Reserve Univ, Cleveland, Ohio
  • Xiaoqin Liu
    Pathology,
    Case Western Reserve Univ, Cleveland, Ohio
  • Christopher Strauch
    Pathology,
    Case Western Reserve Univ, Cleveland, Ohio
  • Vincent M. Monnier
    Pathology and Biochemistry,
    Case Western Reserve Univ, Cleveland, Ohio
  • Footnotes
    Commercial Relationships  Xingjun Fan, None; Shuyu Hao, None; Xiaoqin Liu, None; Christopher Strauch, None; Vincent M. Monnier, None
  • Footnotes
    Support  EY 07099 and the VSRC grant P30EY-11373
Investigative Ophthalmology & Visual Science April 2011, Vol.52, 4752. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Xingjun Fan, Shuyu Hao, Xiaoqin Liu, Christopher Strauch, Vincent M. Monnier; Lens Crystallin Modification and Aggregation by Ascorbic Acid Oxidation: In Vitro and In Vivo Study. Invest. Ophthalmol. Vis. Sci. 2011;52(14):4752.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : Senile cataracts are associated with progressive oxidation, fragmentation, cross-linking, insolubilization, and yellow pigmentation of lens crystallins, a phenomenon that was reproduced in the hSVCT2 transgenic mouse.(PNAS,2006). At 12 mos of age all AGEs attributable to ASA (pentosidine, CML, K2P, vesperlysine A and total fluorescence) were highly significantly increased, and the lenses were yellow like those from a 70 yrs old human lens. We now further determined other modification and crystallin aggregation both in vitro and in vivo by ascorbic acid oxidation.

Methods: : Mouse lens protein extract and recombinant mouse gamma D crystallin were incubated with ASA (3 mM) or dehydroascorbic acid (100uM) under anaerobic condition and analyzed by either LC/MS/MS tandem mass sequencing or LC/MS of protease digest for protein modifications. A 1:1 ratio of C12 and universal labeled C13 labeled ASA were used for unknown modification identification. The protein turbidity was measured spectrophotometrically at 550nm. For in vivo study, young and old age hSVCT2 transgenic mouse lenses protein were extracted. The modifications were quantitively determined by LC/MS. Protein aggregation was determined by light scattering measurement.

Results: : NΔ-(5-hydro-5-methyl-4-imidazolon-2-yl)-ornithine (MG-H1), the most abundant AGEs in human lens was identified in mouse lens protein extract following incubation with ASA. R10, R95, R147 of gamma D crystallin; R95, R163, R180 of gamma F crystallin and R186 of alpha A crystallin formed methylglyoxal hydroimidazolones (MG-H1). MG-H1 was also found significantly elevated in transgenic hSVCT2 mouse lens both with LC/MS and western-blot using MG-H1 antibody. 3-deoxythreosone arginine adduct was also found in gamma D, F and alpha A crystallin by in vitro incubation. ASA caused gamma D crystallin aggregation during in vitro incubation in less than 36 hours. Aggregation could be significantly blocked by co-incubation with either DTT or GSH, indicating that disulfide formation may play an important role in gamma D crystallin precipitation or aggregation. QLS analysis of transgenic mouse lens protein extract showed that proteins eluting in the HMW fraction of the Superose column form aggregates about 4x larger in size than those normally present in WT mouse, providing support to our hypothesis that protein ascorbylation enhances aggregation in vivo.

Conclusions: : These results show that ASA oxidation and modification unequivocally proceed in the aging lens, resulting in crosslinking and aggregation.

Keywords: crystallins • oxidation/oxidative or free radical damage • aging 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×